What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Gene
Adriano Chiò mainly focuses on Amyotrophic lateral sclerosis, Genetics, Incidence, Epidemiology and Internal medicine.
His Amyotrophic lateral sclerosis research incorporates elements of Physical therapy and Neuroscience.
His studies deal with areas such as Global health, Demography, Surgery and Pediatrics as well as Incidence.
His work in Epidemiology covers topics such as Prospective cohort study which are related to areas like Respiratory function and Severity of illness.
The various areas that Adriano Chiò examines in his Internal medicine study include Gastroenterology and Endocrinology.
Adriano Chiò combines subjects such as C9orf72 Protein, Trinucleotide repeat expansion and UBQLN2 with his study of TARDBP.
His most cited work include:
- A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD (2859 citations)
- Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS (917 citations)
- State of play in amyotrophic lateral sclerosis genetics (916 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Amyotrophic lateral sclerosis, Internal medicine, Disease, Pathology and Genetics.
His Amyotrophic lateral sclerosis study integrates concerns from other disciplines, such as Epidemiology, Frontotemporal dementia, Physical therapy, Neuroscience and Cohort.
His research investigates the connection with Epidemiology and areas like Incidence which intersect with concerns in Demography.
His research in Internal medicine intersects with topics in Gastroenterology and Oncology.
His work carried out in the field of Disease brings together such families of science as Neurology and Intensive care medicine.
His work on Genetics deals in particular with Gene, TARDBP, C9orf72, Missense mutation and Mutation.
He most often published in these fields:
- Amyotrophic lateral sclerosis (63.03%)
- Internal medicine (22.41%)
- Disease (18.77%)
What were the highlights of his more recent work (between 2018-2021)?
- Amyotrophic lateral sclerosis (63.03%)
- Disease (18.77%)
- Internal medicine (22.41%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Amyotrophic lateral sclerosis, Disease, Internal medicine, Frontotemporal dementia and Clinical trial.
His research integrates issues of Genetics, Cognition, Neuroscience, C9orf72 and Cohort in his study of Amyotrophic lateral sclerosis.
His study on Disease also encompasses disciplines like
- Cell type, which have a strong connection to Genetic analysis, Signal transduction and Biological pathway,
- Mendelian randomization, which have a strong connection to Genome-wide association study.
His Internal medicine research incorporates themes from Gastroenterology, Oncology and Cardiology.
His Frontotemporal dementia research is multidisciplinary, incorporating elements of Genetic heterogeneity, Hypermetabolism, Neurodegeneration and Neuropsychological assessment.
His Clinical trial research includes elements of Respiratory function, Placebo, MEDLINE and Intensive care medicine.
Between 2018 and 2021, his most popular works were:
- Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. (45 citations)
- Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial (41 citations)
- Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis (41 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Adriano Chiò spends much of his time researching Amyotrophic lateral sclerosis, Disease, Internal medicine, Clinical trial and Cohort.
His Amyotrophic lateral sclerosis research integrates issues from Genetics, Logistic regression, Dementia, Frontotemporal dementia and Cognition.
Adriano Chiò has included themes like Referral, Neuroimaging and Median survival in his Frontotemporal dementia study.
As a member of one scientific family, he mostly works in the field of Disease, focusing on Family history and, on occasion, Trinucleotide repeat expansion, Comorbidity, Weakness, Wasting and Bioinformatics.
In his study, Precentral gyrus, Hypermetabolism, Precuneus, Fluorodeoxyglucose and Superior frontal gyrus is strongly linked to Cardiology, which falls under the umbrella field of Internal medicine.
Adriano Chiò has researched Clinical trial in several fields, including MEDLINE, Randomized controlled trial, Intensive care medicine, Placebo and Riluzole.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
